Reata Pharmaceuticals, Inc.

RETANASDAQHealthcare

$172.36

+$0.04(+0.02%)

Market Cap$6.6B

P/E Ratio—

52W High$172.46

52W Low$21.83

Avg Volume969K

Open$172.34

Beta1.42

Employees Ownership Insider Trades

Reata Pharmaceuticals, Inc. (RETA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RETA · as of Feb 24, 2023

Latest filing snapshot

321

+221+221.00%vs prior year

Reata Pharmaceuticals, Inc. (RETA) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-12-31·Full-time · Global

Total Employees

321

Change (1Y)

+221

Growth % (1Y)

+221.00%

Revenue / Employee

$6.9K

Net Income / Employee

$-971.7K

Market Cap

$6.6B

RETA Employee Count

2016 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2023-02-24	2022-12-31	321	+221	+221.00%
2022-02-28	2021-12-31	100	-161	-61.69%
2021-03-01	2020-12-31	261	+41	+18.64%
2020-02-19	2019-12-31	220	+97	+78.86%
2019-02-28	2018-12-31	123	+30	+32.26%
2018-03-02	2017-12-31	93	+18	+24.00%
2017-03-03	2016-12-31	75	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Blueprint Medicines Corporation

682$8.4B #3

CERE

Cerevel Therapeutics Holdings, Inc.

355$8.2B #4

RETA

Reata Pharmaceuticals, Inc.YOU

Alpine Immune Sciences, Inc.

142$4.5B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RETA peer comparison

About RETA employees

RETA Employees · Headcount

Reata Pharmaceuticals, Inc. (RETA) employee data is sourced from the annual SEC 10-K filing. As of 2022, Reata Pharmaceuticals, Inc. had 321 full-time employees globally. Full-time employees only. Global consolidated headcount.

Reata Pharmaceuticals, Inc. employs 321 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $6,903, reflecting the company's operational efficiency.

Reata Pharmaceuticals, Inc.'s workforce increased by 221 (221.00%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Reata Pharmaceuticals, Inc.'s revenue per employee of $6,903 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

RETA Employees · 5 questions

As of the latest SEC 10-K filing (2022), Reata Pharmaceuticals, Inc. had 321 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Reata Pharmaceuticals, Inc. employee counthow many employees does Reata Pharmaceuticals, Inc. haveRETA total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-02-24